Novo Nordisk, the Danish company behind two popular obesity medications, is reaping huge profits and is now responsible for most of the country’s economic growth.
Category: Diabetes
-
Wegovy, the Weight Loss Drug, Relieves Heart Failure Symptoms: Drugmaker’s Study
The drug Wegovy eased issues for people with a type of heart problem, adding to the treatment’s benefits beyond weight loss.
-
What Is ‘Food Noise’? How Ozempic Quiets Obsessive Thinking About Food
For some, it’s a startling side effect.
-
California’s Plan for Cheaper Insulin Collides With Big Pharma’s Price Cuts
The state awarded a $50 million contract to produce less costly treatments, but moves by major suppliers might undercut the initiative before any new product emerges.
-
Sanofi Plans to Cut the Price of Insulin
The company is the third of the three major insulin manufacturers that dominate the U.S. market to announce such a move this month.
-
Garrett Mitchell of Brewers Balances Baseball and Type 1 Diabetes
Baseball wants more stolen bases, and Garrett Mitchell, a rookie outfielder for the Milwaukee Brewers, is happy to oblige.
-
Eli Lilly Says It Will Cut the Price of Insulin
The company said it would cap the monthly out-of-pocket cost of the diabetes drug at $35.
-
Those Weight Loss Drugs May Do a Number on Your Face
People using drugs like Ozempic are discovering an unwanted side affect: facial aging.
-
California Sues Companies Over Insulin Prices, Joining Other States
The state is taking action against three major drug companies and the big pharmacy benefit managers in an effort to temper costs for people with diabetes.
-
Medicare Begins to Rein In Drug Costs for Older Americans
Reforms embedded in the Inflation Reduction Act will bring savings to seniors this year. Already some lawmakers are aiming to repeal the changes.